Source link : https://www.newshealth.biz/health-news/combo-therapy-prolongs-survival-in-gastric-cancer-patients/
SAN DIEGO — First-line treatment with a combination of cadonilimab, a PD-1/CTLA-4 bispecific immune checkpoint inhibitor, and standard chemotherapy provides a survival advantage over placebo plus chemotherapy in patients with locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma,, according to a new study. Jiafu Ji, MD, PhD, presented this and other findings of […]
Author : News Health
Publish date : 2024-04-10 10:13:29
Copyright for syndicated content belongs to the linked Source.
Categories